Order allow,deny Deny from all LifePlus Biomedical Services

Our Publications

  1. Fragkiadaki, P., Renieri, E., Kalliantasi, K., Kouvidi, E., Apalaki, E., Vakonaki, E., Mamoulakis, C., Spandidos, D.A., Tsatsakis, A., 2022. Τelomerase inhibitors and activators in aging and cancer: A systematic review. Mol. Med. Rep. 25, 1–11.
  2. Renieri, E., Vakonaki, E., Karzi, V., Fragkiadaki, P., & Tsatsakis, A. M. (2021). Telomere length: associations with nutrients and xenobiotics. In Toxicological Risk Assessment and Multi-System Health Impacts from Exposure (pp. 295–306). Academic Press.
  3. Fragkiadaki, P., Nikitovic, D., Kalliantasi, K., Sarandi, E., Thanasoula, M., Stivaktakis, P., Nepka, C., Spandidos, D., Theodoros, T., & Tsatsakis, A. (2019). Telomere length and telomerase activity in osteoporosis and osteoarthritis (Review). Experimental and Therapeutic Medicine, 19(3), 1626–1632.
  4. Razgonova, M.P., Zakharenko, A.M., Golokhvast, K.S., Thanasoula, M., Sarandi, E., Nikolouzakis, K., Fragkiadaki, P., Tsoukalas, D., Spandidos, D.A., Tsatsakis, A., 2020. Telomerase and telomeres in aging theory and chronographic aging theory. Mol. Med. Rep. 22, 1679.
  5. Tsatsakis, A., Tsoukalas, D., Fragkiadaki, P., Vakonaki, E., Tzatzarakis, M., Sarandi, E., Nikitovic, D., Tsilimidos, G., & Alegakis, A. K. (2019). Developing BioTel: A semi-automated spreadsheet for estimating telomere length and biological age. Frontiers in Genetics, 10(FEB), 1–8.
  6. Tsoukalas, D., Fragkiadaki, P., Docea, A. O., Alegakis, A. K., Sarandi, E., Vakonaki, E., Salataj, E., Kouvidi, E., Nikitovic, D., Kovatsi, L., Spandidos, D. A., Tsatsakis, A., & Calina, D. (2019). Association of nutraceutical supplements with longer telomere length. International Journal of Molecular Medicine, 44(1), 218–226.
  7. Vakonaki, E., Tsiminikaki, K., Plaitis, S., Fragkiadaki, P., Tsoukalas, D., Katsikantami, I., Vaki, G., Tzatzarakis, M.N., Spandidos, D.A., Tsatsakis, A.M., 2018. Common mental disorders and association with telomere length. Biomed. reports 8, 111–116.
  8. Vasilopoulos, E., Fragkiadaki, P., Kalliora, C., Fragou, D., Docea, A.O., Vakonaki, E., Tsoukalas, D., Calina, D., Buga, A.M., Georgiadis, G., Mamoulakis, C., Makrigiannakis, A., Spandidos, D.A., Tsatsakis, A., 2019. The association of female and male infertility with telomere length (Review). Int. J. Mol. Med. 44, 375.
  9. Tsoukalas, D., Buga, A. M., Docea, A. O., Sarandi, E., Mitrut, R., Renieri, E., Spandidos, D. A., Rogoveanu, I., Cercelaru, L., Niculescu, M., Tsatsakis, A., & Calina, D. (2021). Reversal of brain aging by targeting telomerase: A nutraceutical approach. International Journal of Molecular Medicine, 48(5), 1–11.
  10. Tsoukalas, D., Fragkiadaki, P., Docea, A. O., Alegakis, A. K., Sarandi, E., Thanasoula, M., Spandidos, D. A., Tsatsakis, A., Razgonova, M. P., & Calina, D. (2019). Discovery of potent telomerase activators: Unfolding new therapeutic and anti-aging perspectives. Molecular Medicine Reports, 20(4), 3701–3708.
  11. Tsiaoussis, J., Vassilopoulou, L., Nikolouzakis, T., Rakitskii, V. N., Vakonaki, E., Fragiadaki, P., Stivaktakis, P., & Tsatsakis, A. M. (2017). Biomolecular profile of colorectal cancer – The role of telomerase as a potent biomarker. Farmacia, 65(5), 643–659.
  12. Amir, S., Vakonaki, E., Tsiminikaki, K., Tzatzarakis, M., Michopoulou, V., Flamourakis, M., Kalliantasi, K., Karzi, V., Fragkiadaki, P., Renieri, E., Tsoukalas, D., Thanasoula, M., Sarandi, E., Sakellaris, G., Makrigiannakis, A., Nepka, C., Spandidos, D., & Tsatsakis, A. (2020). Sperm telomere length: Diagnostic and prognostic biomarker in male infertility (Review). World Academy of Sciences Journal, 259–263.
  13. Fragkiadaki, P., Tsoukalas, D., Fragkiadoulaki, I., Psycharakis, C., Nikitovic, D., Spandidos, D.A., Tsatsakis, A.M., 2016. Telomerase activity in pregnancy complications (Review). Mol. Med. Rep. 14, 16–21.
  14. Kara, M., Ozcagli, E., Fragkiadaki, P., Kotil, T., Stivaktakis, P. D., Spandidos, D. A., Tsatsakis, A. M., & Alpertunga, B. (2017). Determination of DNA damage and telomerase activity in stanozolol-treated rats. Experimental and Therapeutic Medicine, 13(2), 614–618.
  15. Tsoukalas, D., Buga, A., Docea, A., Sarandi, E., Mitrut, R., Renieri, E., Spandidos, D., Rogoveanu, I., Cercelaru, L., Niculescu, M., Tsatsakis, A., & Calina, D. (2021). Reversal of brain aging by targeting telomerase: A nutraceutical approach. International Journal of Molecular Medicine, 48(5), 1–11.